CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.
October 21st 2024
Whenever I get sick, I experience a few side effects that usually go away, but unexplained weight loss becomes a problem for me.
September 23rd 2024
FDA Approves Keytruda for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma
October 15th 2020Data from the trial that led to the FDA approval demonstrated that Keytruda reduced the risk of progression or death in patients with relapsed or refractory classical Hodgkin lymphoma by 35%, compared to Adcetris.
FDA Provides Updated Analysis of Breast Implant-Associated Lymphoma, Breast Implant Illness
August 21st 2020The FDA also released a video for patients that details seven things they should know about breast implants, including information about breast implant-associated lymphoma and systemic symptoms.
Novel CAR T-Cell Therapy Shows Promise in Advanced Hodgkin Lymphoma
August 14th 2020“Unlike other CAR T-cell therapies, clinical success was not associated with significant complications from therapy,” said Dr. Jonathan Serody. “This means this treatment should be available to patients in a clinic setting and would not require patients to be hospitalized, which is critical in our current environment.”
Expert Explains Potential Long-term Impact of Yescarta CAR-T Cell Therapy For Patients with Lymphoma
June 18th 2020Dr. Caron A. Jacobson discusses the potential long-term impact of Yescarta for patients with relapsed or refractory indolent non-Hodgkin lymphoma and how it could turn an incurable disease into something curable.